The renal tubular damage marker urinary N-acetyl-β-d-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes

Cardiovascular Diabetology

Volumn 16, Issue 1, 2017, Pages

  Kim, So Ra ^a,b   Lee, Yong ho ^a,b   Lee, Sang Guk ^a   Kang, Eun Seok ^a,b   Cha, Bong Soo ^a,b   Lee, Byung Wan ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Carotid intima media thickness; Carotid plaque; N acetyl d glucosaminidase; Type 2 diabetes mellitus

Indexed keywords

N ACETYL BETA GLUCOSAMINIDASE; ACETYLGLUCOSAMINIDASE; BIOLOGICAL MARKER; CREATININE;

ADULT; ALBUMINURIA; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; GLOMERULOPATHY; HUMAN; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CODING; PREDICTIVE VALUE; AGED; CAROTID ARTERY DISEASES; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYMOLOGY; KIDNEY TUBULE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDY; STATISTICAL MODEL; URINALYSIS; URINE;

ACETYLGLUCOSAMINIDASE; AGED; ALBUMINURIA; BIOMARKERS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; FEMALE; HUMANS; KIDNEY TUBULES; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; URINALYSIS;

EID: 85010378976     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-017-0497-7     Document Type: Article

References (40)

1. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation. 2006;113(25):2943-6.
2. Ishimura E, Taniwaki H, Tsuchida T, Obatake N, Emoto M, Shoji T, et al. Urinary albumin excretion associated with arterial wall stiffness rather than thickness in type 2 diabetic patients. J Nephrol. 2007;20(2):204-11.
3. Mule G, Cottone S, Cusimano P, Riccobene R, Palermo A, Geraci C, et al. The association of microalbuminuria with aortic stiffness is independent of C-reactive protein in essential hypertension. Am J Hypertens. 2009;22(10):1041-7.
4. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340(1):14-22.
5. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care. 1996;19(11):1243-8.
6. Huang Y, Chen Y, Xu M, Gu W, Bi Y, Li X, et al. Low-grade albuminuria is associated with carotid intima-media thickness in Chinese type 2 diabetic patients. J Clin Endocrinol Metab. 2010;95(11):5122-8.
7. Ishikawa T, Hashimoto J, Morito RH, Hanazawa T, Aikawa T, Hara A, et al. Association of microalbuminuria with brachial-ankle pulse wave velocity: the Ohasama study. Am J Hypertens. 2008;21(4):413-8.
8. Mule G, Cottone S, Vadala A, Volpe V, Mezzatesta G, Mongiovi R, et al. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med. 2004;256(1):22-9.
9. Choi SW, Yun WJ, Kim HY, Lee YH, Kweon SS, Rhee JA, et al. Association between albuminuria, carotid atherosclerosis, arterial stiffness, and peripheral arterial disease in Korean type 2 diabetic patients. Kidney Blood Press Res. 2010;33(2):111-8.
10. Li MF, Tu YF, Li LX, Lu JX, Dong XH, Yu LB, et al. Low-grade albuminuria is associated with early but not late carotid atherosclerotic lesions in community-based patients with type 2 diabetes. Cardiovasc Diabetol. 2013;12:110.
11. Nauta FL, Boertien WE, Bakker SJ, van Goor H, van Oeveren W, de Jong PE, et al. Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care. 2011;34(4):975-81.
12. Kim SR, Lee Y-h, Lee S-G, Kang ES, Cha B-S, Kim J-H, et al. Urinary N-acetyl-β-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes. Medicine. 2016;95(27):e4114.
13. Shimojo N, Kitahashi S, Naka K, Fujii A, Okuda K, Tanaka S, et al. Comparison of N-acetyl-β-d-glucosaminidase and alanine aminopeptidase activities for evaluation of microangiopathy in diabetes mellitus. Metabolism. 1987;36(3):277-80.
14. Kopf S, Oikonomou D, Zdunek D, von Eynatten M, Hess G, Nawroth PP, et al. Urinary N-acetyl-β-d-glucosaminidase excretion: an indicator of neuropathy in type 2 diabetes. Exp Clin Endocrinol Diabetes. 2013;121(10):601-6.
15. Weitgasser R, Schnoell F, Gappmayer B, Kartnig I. Prospective evaluation of urinary N-acetyl-β-d-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care. 1999;22(11):1882-6.
16. Moon JH, Chae MK, Kim KJ, Kim HM, Cha BS, Lee HC, et al. Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented ischemic disease. Circ J. 2012;76(9):2273-9.
17. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290-6.
18. Global guideline for Type 2 diabetes. International Diabetes Federation Clinical Guidelines Task Force, Brussels. 2005. http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf. Accessed 1 Oct 2005.
19. Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, Takeuchi Y, et al. The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol. 2010;9:18.
20. Bednarski R, Kubalski P, Stefańska A, Odrowaz-Sypniewska G, Manitius J. Renal tubulointerstitial tissue damage, central pressure and vascular function in patients with untreated primary arterial hypertension. Arter Hypertens. 2015;19(1):29-38.
21. Damman K, Masson S, Hillege HL, Maggioni AP, Voors AA, Opasich C, et al. Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J. 2011;32(21):2705-12.
22. Pitkanen E, Kyllastinen M, Koivula T, Hormila P. β-N-acetylglucosaminidase and β-glucuronidase activities in insulin-dependent diabetic subjects with retinopathy. Diabetologia. 1980;18(4):275-8.
23. Ouchi M, Oba K, Saigusa T, Watanabe K, Ohara M, Matsumura N, et al. Association between pulse wave velocity and a marker of renal tubular damage (N-acetyl-β-d-glucosaminidase) in patients without diabetes. J Clin Hypertens (Greenwich). 2015;17(4):290-7.
24. Solbu MD, Toft I, Lochen ML, Mathiesen EB, Eriksen BO, Melsom T, et al. N-Acetyl-β-d-glucosaminidase does not enhance prediction of cardiovascular or all-cause mortality by albuminuria in a low-risk population. J Am Soc Nephrol. 2016;27(2):533-42.
25. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421-6.
26. Leoncini G, Sacchi G, Viazzi F, Ravera M, Parodi D, Ratto E, et al. Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. J Hypertens. 2002;20(7):1315-21.
27. Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, Takeuchi Y, et al. The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol. 2010;9:18.
28. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol. 2006;17(1):17-25.
29. Sheira G, Noreldin N, Tamer A, Saad M. Urinary biomarker N-acetyl-β-d-glucosaminidase can predict severity of renal damage in diabetic nephropathy. J Diabetes Metab Disord. 2015;14:4.
30. Kadokura T, Saito M, Utsuno A, Kazuta K, Yoshida S, Kawasaki S, et al. Ipragliflozin (ASP1941), a selective sodium-dependent glucose cotransporter 2 inhibitor, safely stimulates urinary glucose excretion without inducing hypoglycemia in healthy Japanese subjects. Diabetol Int. 2011;2(4):172-82.
31. Kern EF, Erhard P, Sun W, Genuth S, Weiss MF. Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT). Am J Kidney Dis. 2010;55(5):824-34.
32. Lee EY, Lee BW, Kim D, Lee YH, Kim KJ, Kang ES, et al. Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Acta Diabetol. 2011;48(2):167-72.
33. Kim D, Kim KJ, Huh JH, Lee BW, Kang ES, Cha BS, et al. The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function. Clin Endocrinol (Oxf). 2012;77(5):679-83.
34. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, et al. Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care. 1992;15(10):1290-4.
35. Lim JS, Choi YJ, Kim SK, Huh BW, Lee EJ, Huh KB. Optimal waist circumference cutoff value based on insulin resistance and visceral obesity in Koreans with Type 2 diabetes. Diabetes Metab J. 2015;39(3):253-63.
36. Oh H-G, Nallamshetty S, Rhee E-J. Increased risk of progression of coronary artery calcification in male subjects with high baseline waist-to-height ratio: The Kangbuk Samsung Health Study. Diabetes Metab J. 2016;40(1):54-61.
37. Peng Y, Wang H, Chen F, Huang FY, Xia TL, Liao YB, et al. The influence of body composition on renal function in patients with coronary artery disease and its prognostic significance: a retrospective cohort study. Cardiovasc Diabetol. 2016;15(1):106.
38. Freedman BI, Langefeld CD, Lohman KK, Bowden DW, Carr JJ, Rich SS, et al. Relationship between albuminuria and cardiovascular disease in Type 2 diabetes. J Am Soc Nephrol. 2005;16(7):2156-61.
39. Costanzo P, Perrone-Filardi P, Vassallo E, Paolillo S, Cesarano P, Brevetti G, et al. Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. J Am Coll Cardiol. 2010;56(24):2006-20.
40. Sagara M, Suzuki K, Aoki C, Tanaka S, Taguchi I, Inoue T, et al. Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study. Cardiovasc Diabetol. 2016;15:76.